Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
9.78
-0.11 (-1.11%)
At close: Jun 13, 2025, 4:00 PM
10.09
+0.31 (3.14%)
After-hours: Jun 13, 2025, 7:38 PM EDT
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $753.91 million as of June 13, 2025. Its market cap has increased by 145.02% in one year.
Market Cap
753.91M
Enterprise Value
346.27M
1-Year Change
145.02%
Ranking
Category
Stock Price
$9.78
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $753.91M, an increase of 61.26%. That is a compound annual growth rate of 7.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 727.50B |
| Johnson & Johnson | 372.85B |
| Novo Nordisk | 353.20B |
| AbbVie | 338.80B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 234.88B |
| Novartis AG | 232.35B |
| AstraZeneca | 229.07B |